NEW YORK, NY--(Marketwire - July 13, 2012) - TriMarkPublications.com cites in its newly published "Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets" report that the worldwide IVD market will catapult to $82 billion by 2017. For more information, visit: http://www.trimarkpublications.com/clinical-laboratory-testing-volume-1-ivd-reagents-and-instruments-markets.
Clinical laboratory testing detects levels of enzymes, sugars, proteins and other substances in the blood to help identify conditions like diabetes, hyperlipidemia and arteriosclerosis during clinical diagnoses and as part of regular health checkups. Over 750 million clinical laboratory tests will be carried out in U.S. hospitals in 2012. The Asia-Pacific region will experience the fastest growth, accounting for 32% of the world market by 2017.
The "Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets" report covers:
- Clinical Laboratory Instrument Markets
- Immunochemistry Analyzers
- Hematology Analyzers
- Microbiology Testing
- Serology Testing
- Esoteric Testing
- Anatomic Pathology
- Point of Care Testing
- Biotechnology Reagents and Supplies
- Automated Instrument Platforms Evolution
The "Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets" report examines companies manufacturing clinical laboratory testing equipment and supplies in the world. Companies covered include: Abaxis, Abbott, Adaltis, Alfa Wasserman, Beckman Coulter, Becton Dickinson, bioMérieux, Hitachi, Hologic, Horiba, JEOL, MEDTOX, Myriad Genetics, Nova Biomedical, Ortho-Clinical, Roche Diagnostics, Shimadzu, Sysmex, Thermo Fisher, Tosoh and Vital.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/clinical-laboratory-testing-volume-1-ivd-reagents-and-instruments-markets.
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.